Industry Experts Discuss Recombinant Human Insulins – Clinical Efficacy and Safety in Diabetes Therapy
LONDON, April 21, 2016 /PRNewswire/ – Published recently in European Endocrinology, the peer-reviewed journal from touchENDOCRINOLOGY, Wolfgang Landgraf and Juergen Sandow discusses how insulin replacement therapy is the standard of care for patients with type 1 and advanced type 2 diabetes mellitus.